ECL
45
-2
KHC
42
4
HAS
44
2
ACN
33
4
FRT
50
4
BIIB
48
4
L
56
-6
ITW
37
-11
DG
40
2
HOG
45
2
HPE
34
17
GIS
60
3
EFX
61
3
AZO
55
-8
GME
54
3
FDX
37
4
KMI
81
6
EQR
47
2
AMG
60
8
CMG
47
-3
ECL
45
-2
KHC
42
4
HAS
44
2
ACN
33
4
FRT
50
4
BIIB
48
4
L
56
-6
ITW
37
-11
DG
40
2
HOG
45
2
HPE
34
17
GIS
60
3
EFX
61
3
AZO
55
-8
GME
54
3
FDX
37
4
KMI
81
6
EQR
47
2
AMG
60
8
CMG
47
-3
Financhill
Back

Windtree Therapeutics 10K Form

Sell
19

WINT
Windtree Therapeutics

Last Price:
$1.93
Seasonality Move:
-6.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q WINT/Windtree Therapeutics Quarterly
2023-08-07 10Q WINT/Windtree Therapeutics Quarterly
2023-05-15 10Q WINT/Windtree Therapeutics Quarterly
2022-11-14 10Q WINT/Windtree Therapeutics Quarterly
2022-08-11 10Q WINT/Windtree Therapeutics Quarterly
2022-05-05 10Q WINT/Windtree Therapeutics Quarterly

Receive WINT News And Ratings

See the #1 stock for the next 7 days that we like better than WINT

WINT Financial Statistics

Sales & Book Value

Annual Sales: $198K
Cash Flow: $-6.4M
Price / Cash Flow: 0
Annual Sales: $1.88
Price / Book: 0.35

Profitability

EPS (TTM): -16.53000
Net Income (TTM): $-9.7M
Gross Margin: $2M
Return on Equity: 0%
Return on Assets: 0%

Windtree Therapeutics Earnings Forecast

Key Windtree Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 22 years for WINT is 99.90%.
  • The Selling, General & Administrative Expenses for WINT have been equal to 6,264.65% of Gross Profit Margin.
  • Per Share Earnings over the last 29 years have been positive in 12 years.

Windtree Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: WINT
CUSIP: 97382D
Website: windtreetx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

WINT Technical Analysis vs Fundamental Analysis

Sell
19
Windtree Therapeutics (WINT) is a Sell

Is Windtree Therapeutics a Buy or a Sell?